-
Mashup Score: 0
PostAaron Logan, MD, PhD, MPhil@hemedoc#tandem24 #bmtsm Cutler: Signif lower incidence of steroid requiring cGVHD in the Obi arm. No impact on incidence of overall cGVHD, relapse, or TRM.9:24 PM · Feb 22, 2024207 Views1 Quote1 LikeNew to X?Sign up now to get your own personalized timeline!Sign up with AppleCreate accountBy signing up, you agree to the Terms of Service and Privacy Policy,…
Source: x.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Building a Community of Hope | INTO HLH Registry - 2 month(s) ago
The Registry is aimed at advancing what is known about HLH and will help doctors to better diagnose and manage HLH and improve treatment outcomes for future patients
Source: hlhregistry.orgCategories: General Medicine News, Hem/OncsTweet-
#tandem24 Jordan: https://t.co/sz3MTE3VA2 recruiting patients of all ages and all types of HLH to better understand the syndrome. Patients can self-consent on the site. 🆒
-
-
Mashup Score: 3Maui Strong Fund - 9 month(s) ago
Maui Strong
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @MazieTsangMD: Resources for #MauiFires Please donate to: https://t.co/NIwRCIZAIo @HCFHawaii donates 100% of proceeds to local non-pr…
-
-
Mashup Score: 38Sign the Petition - 9 month(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
It’s nice to see so many others rallying around elimination of ABIM’s cartel-like behavior and extortion via MOC fees. I signed the petition, of course. Kudos to @AaronGoodman33 for rolling this out. Next step is to get press coverage to spread the word. https://t.co/UU7JIFhXeX https://t.co/z0YoGE9o2Y
-
-
Mashup Score: 2curate.ai - Domain Name For Sale | Dan.com - 11 month(s) ago
I found a great domain name for sale on Dan.com. Check it out!
Source: DAN.COMCategories: Hem/Oncs, Latest HeadlinesTweet-
#ASCO23 #ai #aimedsm Ho: Developing a digital avatar for a pt would implement #deeplearning to make decisions for optimal tx for a pt. Right drug at right time is another dimension beyond right regime for right dx. https://t.co/cy84jMiETX a digital avatar tool in development. https://t.co/CUyAkIrEZQ
-
-
Mashup Score: 0Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis - 1 year(s) ago
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe, dysregulated inflammation driven by the inability of T cells to clear an antigenic target. When associated with malignancy (mHLH), the HLH syndrome is typically associated with extremely poor survival. Here, we review the diagnosis of secondary HLH (sHLH) syndromes in adults, with emphasis on the appropriate workup and treatment of…
Source: MDPICategories: Hem/Oncs, Latest HeadlinesTweet-
Jerry Lee @TheBloodDoc and I are pleased to share this guide for diagnosis and management of adult malignancy-associated hemophagocytic lymphohistiocytosis (#HLH), pub'd 3/18/23 https://t.co/OdBHH58PdF #mdpicancers via @Cancers_MDPI
-
-
Mashup Score: 0
Ravi B. Parikh, MD, MPP, explores the evidence-based oncology movement, which started off promising but transformed into takedowns of trials, investigators, and the FDA.
Source: MedscapeCategories: Hem/Oncs, Latest HeadlinesTweet-
This * 💯,000,000! Must read piece by @ravi_b_parikh. 👏🏻 Why Evidence-Based Medicine Fans Could Use a Lesson in Persuasion https://t.co/ZjXX1nZb3y via @medscape
-
-
Mashup Score: 0News Releases | Talaris Therapeutics, Inc. - 1 year(s) ago
The Investor Relations website contains information about Talaris Therapeutics, Inc.’s business for stockholders, potential investors, and financial analysts.
Source: Talaris Therapeutics Inc.Categories: Hem/Oncs, Latest HeadlinesTweet-
We’ve been working quite hard to open the @TalarisTx Freedom-1 trial for combined allo kidney/HCT for tolerance induction. Sad to see just now the protocol is being abandoned… :( https://t.co/DSrV6bzPtD
-
-
Mashup Score: 3The road to purified hematopoietic stem cell transplants is paved with antibodies - PubMed - 1 year(s) ago
Hematopoietic progenitor cell replacement therapy remains a surprisingly unrefined process. In general, unmanipulated bone marrow or mobilized peripheral blood (MPB) grafts which carry potentially harmful passenger cells are administered after treating recipients with high-dose chemotherapy and/or r …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#tandem23 #bmtsm I wrote this paper over 10 years ago but mAb conditioning has been a slow moving part of HCT field, so actually still relevant https://t.co/t8wH6s0IPi
-
-
Mashup Score: 0The Future of Chronic Graft-Versus-Host Disease | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination December 30, 2021 Senior Clinician, Immune Deficiency Cellular Therapy Program, National Cancer InstituteInvestigator and Director, Michael Cuccione Childhood Cancer Research Program, BC…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
@barttels2 @RahulBanerjeeMD Yes, indeed. Considered an orphan disease from drug development perspective. https://t.co/PhgTQoeWeb
-
@timfenske https://t.co/Xra6n2pq5H